# Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

> **NCT06386107** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 212 (estimated)

## Conditions studied

- Cancer
- Pulmonary Embolism
- Thrombosis

## Interventions

- **BIOLOGICAL:** Thrombin Generation Assay (TGA)

## Key facts

- **NCT ID:** NCT06386107
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-02
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386107, "Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06386107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*